Drug targets identified through cell line to potentially treat rare pediatric cancer

21 enero 2015

A team of investigators has made key new findings about an extremely rare childhood cancer called neurocutaneous melanocytosis. This malignant cancer is characterized by an excessive growth of melanin-producing cells in both the skin and the brain. The study’s authors found potential drug targets for the disease by using a molecular analysis of patient tumor cells grown in animal models.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/ZsHumNEGKu8/150121093553.htm

Volver